This analysis shows halogenated cytosine's effectiveness as a radiosensitizer, indicating potential in radiotherapy applications.
Halogenated pyrimidines have been a compound of interest for a long time due to their wide range of applications in biological science. In this study, we sought to evaluate the effectiveness of halogenated cytosine as a radiosensitizer by analyzing its interaction with low-energy electrons produced during radiotherapy. Our results revealed that halogenated cytosine forms a dipole-bound state in the gas phase after electron attachment in the Franck-Condon region. We utilized a nuclear charge stabilization method and employed the regularized analytical continuation technique to determine the position and width of the π* and σ* resonance states in gas-phase halogenated cytosines. The halogenation of cytosine enhances the stability of the π* resonance. The σ* resonance of the C-Cl bond appears at 2.71 eV, whereas for the C-Br bond, it is observed at a lower energy of 1.68 eV. In the condensed phase, stable five-water clusters of halogenated nucleobases [5 - XC(H2O)5] were analyzed using a polarizable continuum model of implicit solvation to study the bulk effect of water. The vertically attached anions were found to be π* valence-bound in nature. From ab initio molecular dynamics simulations, dissociation in the brominated cytosine cluster was predicted, whereas no dissociative processes occurred in the chlorinated and fluorinated clusters.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: